High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial.
'Safe' methaemoglobin concentrations are a mortality risk factor in patients receiving inhaled nitric oxide.
Methemoglobinemia in an infant receiving nitric oxide after the use of eutectic mixture of local anesthetic.
Inhaled nitric oxide and methemoglobin in full-term infants with persistent pulmonary hypertension of the newborn.
Methaemoglobinaemia after inhalation of nitric oxide for treatment of hydrochlorothiazide-induced pulmonary oedema.